Navigation Links
BCC Research Publishes a New Report On Global Markets for Companion Diagnostics

Wellesley, MA (PRWEB) November 27, 2013

According to a new technical market research report, Companion Diagnostics: Technologies and Global Markets from BCC Research (, the global market for companion diagnostics was valued at $1.1 billion in 2012 and is expected to reach $1.2 billion in 2013. BCC Research projects the market to grow to $3.5 billion by 2018, and register a five-year compound annual growth rate of 23.9% from 2013 to 2018.

Personalized medicine is becoming one of the important trends in healthcare today. The companion diagnostic sector is a fast growing part of this new space and has already made a significant impact on the pharmaceutical and diagnostic industries. The drug development industry is currently focusing more on the codevelopment of new therapies in conjunction with its diagnostic or biomarker tests to optimize patient treatment. This area of industry is still relatively young, but it will become more complicated and developed due to numerous successful FDA-approved products. Moreover, the companion diagnostics approach in drug development has reduced the cost of bringing new medicines and therapies to the market.

Intense R&D spending, growing consumer demand for more personalized medicine, and improving access to healthcare will spur tremendous growth in this market for the foreseeable future.

This report from BCC Research provides information on the current state of the companion diagnostic industry, its main market participants, and new technologies in assay development. More importantly, it describes potential novel commercial venues in this area of the healthcare industry. The companion testing market is addressed in different industry segments, including oncology, metabolic disorders, cardiovascular diseases, central nervous system disorders and infectious diseases. Main market participants, trends, and product performances are described for each sector. Numerous different companion diagnostic assays are on the market, but oncology is the most developed segment, with products and tests that represent more than 50% of the market. The report also provides information regarding less-developed sectors of this market, along with a list of current companies that have new companion diagnostic products in development.

In addition to specific product descriptions and industry sector evaluation, this report also summarizes the main industry drivers and challenges and identifies major players, their pharmaceutical partners and newcomers to the market, as well as the ways in which they are all interconnected.

This report is intended for business development professionals, healthcare professionals, entrepreneurs and other investment groups to help them fully understand and evaluate a new, less-familiar area of the healthcare and diagnostic industry. It provides companies’ corporate development departments with new insight into competitors’ positions and shows new opportunities otherwise overlooked or unfamiliar to the public.

Both primary and secondary research methodologies were used to prepare this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, product and promotional literature, annual reports, security analyst reports and other publications. Patent searches and analyses were also conducted.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global And China Medical MRI Equipment Industry 2013 Market Research Report
2. Global And China Defibrillator Industry 2013 Market Research Report
3. Researchers at Penn uncover mechanism behind blood stem cells longevity
4. Medical research needs kids, but two-thirds of parents unaware of opportunities
5. Winter Indoor Heating Can Be Health Hazard Warns Water and Health Researcher
6. World Nutraceutical Ingredients Market Worth $30 Billion by 2017 Says a New Research Report at
7. Contract Research Organization WCCT Global Announces Clinical Trial Patient Recruitment Services for International Clinical Studies
8. Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World
9. Western University cancer researcher teams up with Chinese scientists to study chemotherapy
10. Discounted Global Pharma & Biotech Market Research Study by MP Advisors Published at
11. BCC Research Publishes A New Report On Global Markets For Molecular Imaging Devices
Post Your Comments:
(Date:11/14/2019)... DIEGO (PRWEB) , ... November 14, 2019 , ... ... three categories of HREI magazine’s annual, national awards program. The three projects include ... a Federally Qualified Health Center in El Centro, Calif. that provides medical care ...
(Date:11/12/2019)... ... November 12, 2019 , ... Each year, RESOLVE ... truly impacted those diagnosed with infertility. This year, Academy of Adoption and Assisted ... presented at the Night of Hope Gala in New York City on November ...
(Date:11/12/2019)... ... November 12, 2019 , ... InteliChart, the leader in ... Tidewater Physicians Multispecialty Group (TPMG), a network of 220 providers across 85 ... platform to deliver enhanced patient experience and overall engagement to their patients. ...
(Date:11/12/2019)... MESA, Calif. (PRWEB) , ... November 12, 2019 ... ... professional certification, licensing, and compliance management, today announced the release of new features ... feel of Certemy’s platform interface and emails to match their physical brand attributes. ...
(Date:11/11/2019)... ... November 11, 2019 , ... Smile Brands Inc., one ... the United States, today announced the grand opening of another affiliated Bright ... enjoy convenient hours, comfortable offices and full-service care at the new location. The ...
Breaking Medicine News(10 mins):
(Date:11/14/2019)... ... November 14, 2019 , ... Kaden, the digital behavioral health ... crisis in New Hampshire. The company is exploring a collaborative effort with Catholic ... opioid use disorder in the state. , Kaden is pleased to be a ...
(Date:11/14/2019)... ... 14, 2019 , ... Bioclinica Medical Imaging, the world leader ... a milestone in the company’s history: the company has contributed reliable data to ... for therapies and indications subsequently approved by the U.S. Food and Drug Administration. ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... of vinyl, vinyl chloride monomer (VCM), additives, and modifiers, announced recipients of its ... vinyl industry for improving worker safety and protecting the environment at manufacturing facilities ...
Breaking Medicine Technology: